Koefisien utang jangka dawa marang modal Evolus Corp (EOLS)

Evolus, Inc. (EOLS) generates revenue from a high-demand cosmetic product, with consumer habits for regular treatments ensuring steady sales. The brand is popular among plastic surgeons due to the Jeuveau product and modern promotion. The indicator stands at 0.00. The price action on the chart below accounts for advertising costs and a potential decline in consumer spending due to inflation, despite the resolution of patent disputes.

The long-term debt-to-equity ratio measures the proportion of liabilities with maturities exceeding one year within the equity structure, determining the degree of financial stability and long-term credit risk. By analyzing long-term debt leverage, an investor assesses the ability of Evolus, Inc. (EOLS) to maintain a highly specialized single-drug commercialization model amidst pricing competition without excessive debt burden.